Form 8-K - Current report:
SEC Accession No. 0001193125-25-157638
Filing Date
2025-07-10
Accepted
2025-07-10 16:45:32
Documents
15
Period of Report
2025-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933755d8k.htm   iXBRL 8-K 30992
2 EX-10.1 d933755dex101.htm EX-10.1 67604
3 EX-99.1 d933755dex991.htm EX-99.1 9906
7 GRAPHIC g933755dsp20.jpg GRAPHIC 7454
  Complete submission text file 0001193125-25-157638.txt   264279

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vor-20250709.xsd EX-101.SCH 2508
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20250709_lab.xml EX-101.LAB 18699
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20250709_pre.xml EX-101.PRE 11683
17 EXTRACTED XBRL INSTANCE DOCUMENT d933755d8k_htm.xml XML 3859
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 251116759
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)